Home Recalls D-1209-2018
Class II · Moderate risk Terminated Initiated Sep 7, 2018 (8 years ago)
Minivelle (estradiol transdermal system) Patches, Delivers 0.025 mg/day, 8 count boxes…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.
What was recalled
Minivelle (estradiol transdermal system) Patches, Delivers 0.025 mg/day, 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6625-8
Recalling firm Noven Pharmaceuticals, Inc.
NDC code 68968-6625-8
Origin FL, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-1209-2018
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing May 27, 2026
Reason Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
Class II · Moderate risk Ongoing May 12, 2026
Reason Defective Container; packets were found to be either empty or partially full.
Class II · Moderate risk Ongoing Jan 26, 2026
Reason Presence of Foreign substance - potential presence of metal particulate matter
Class II · Moderate risk Ongoing Jan 26, 2026
Reason Presence of Foreign substance - potential presence of metal particulate matter
Class II · Moderate risk Ongoing Jan 26, 2026
Reason Presence of Foreign substance - potential presence of metal particulate matter